Composition and kit for alleviating symptoms of respiratory allergy
US-2024122998-A1 · Apr 18, 2024 · US
US9241965B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9241965-B2 |
| Application number | US-201113821710-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 8, 2011 |
| Priority date | Sep 8, 2010 |
| Publication date | Jan 26, 2016 |
| Grant date | Jan 26, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides a composition for external application to the skin for skin care after laser treatment, which contains Prunus mume extract as an active ingredient. The composition for external application to the skin according to the present disclosure has skin-soothing, skin barrier-recovering and pain-relieving effects and, therefore, can be developed into a cosmetic composition having additional effects of protecting sensitive skin, preventing skin sensitivity, providing skin stability and moisturizing the skin.
Opening claim text (preview).
The invention claimed is: 1. A method for aftercaring a skin after laser treatment to the skin in a subject, comprising transdermally administering an effective amount of Prunus mume extract to the subject after laser treatment to skin, wherein a temperature of the skin is higher than or equal to 45° C. 2. The method according to claim 1 , wherein the Prunus mume extract soothing soothes the skin, relieves skin pain or recovers the skin barrier. 3. The method according to claim 1 , wherein the Prunus mume extract is administered in a form of a composition comprising 0.001-10 wt % of the Prunus mume extract based on the total weight of the composition. 4. The method according to claim 3 , wherein the composition is in the form selected from a group consisting of solution, suspension, emulsion, paste, gel, lotion, cream, essence, pack, soothing mask, topical patch, makeup base, moisturizing oil, powder, soap, surfactant-containing cleanser, oil, powder foundation, emulsion foundation, wax foundation, oil-in-water (O/W) or water-in-oil (W/O) emulsion and spray. 5. The method according to claim 1 , wherein the Prunus mume extract protects sensitive skin, prevents skin sensitivity, provides skin stability and moisturizes the skin after laser treatment.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Drugs for dermatological disorders · CPC title
Magnoliopsida [dicotyledons] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.